Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers
- PMID: 15803497
- DOI: 10.1002/syn.20147
Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers
Abstract
Three metabotropic glutamate receptor subtype 5 (mGluR5) PET tracers have been labeled with either carbon-11 or fluorine-18 and their in vitro and in vivo behavior in rhesus monkey has been characterized. Each of these tracers share the common features of high affinity for mGluR5 (0.08-0.23 nM vs. rat mGluR5) and moderate lipophilicity (log P 2.8-3.4). Compound 1b was synthesized using a Suzuki or Stille coupling reaction with [11C]MeI. Compounds 2b and 3b were synthesized by a SNAr reaction using a 3-chlorobenzonitrile precursor. Autoradiographic studies in rhesus monkey brain slices using 2b and 3b showed specific binding in cortex, caudate, putamen, amygdala, hippocampus, most thalamic nuclei, and lower binding in the cerebellum. PET imaging studies in monkey showed that all three tracers readily enter the brain and provide an mGluR5-specific signal in all gray matter regions, including the cerebellum. The specific signal observed in the cerebellum was confirmed by the autoradiographic studies and saturation binding experiments that showed tracer binding in the cerebellum of rhesus monkeys. In vitro metabolism studies using the unlabeled compounds showed that 1a, 2a, and 3a are metabolized slower by human liver microsomes than by monkey liver microsomes. In vivo metabolism studies showed 3b to be long-lived in rhesus plasma with only one other more polar metabolite observed.
(c) 2005 Wiley-Liss, Inc.
Similar articles
-
Synthesis, characterization, and monkey PET studies of [¹⁸F]MK-1312, a PET tracer for quantification of mGluR1 receptor occupancy by MK-5435.Synapse. 2011 Feb;65(2):125-35. doi: 10.1002/syn.20826. Synapse. 2011. PMID: 20524178
-
Screening cascade and development of potential Positron Emission Tomography radiotracers for mGluR5: in vitro and in vivo characterization.Mol Imaging Biol. 2005 Jul-Aug;7(4):314-23. doi: 10.1007/s11307-005-0005-4. Mol Imaging Biol. 2005. PMID: 16080024
-
Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB.Nucl Med Biol. 2007 Nov;34(8):1009-17. doi: 10.1016/j.nucmedbio.2007.07.009. Epub 2007 Sep 19. Nucl Med Biol. 2007. PMID: 17998106
-
Recent developments of the PET imaging agents for metabotropic glutamate receptor subtype 5.Curr Top Med Chem. 2007;7(18):1800-5. doi: 10.2174/156802607782507394. Curr Top Med Chem. 2007. PMID: 17979788 Review.
-
Radiosynthesis of carbon-11 and fluorine-18 labelled radiotracers to image the ionotropic and metabotropic glutamate receptors.J Labelled Comp Radiopharm. 2013 Mar-Apr;56(3-4):180-6. doi: 10.1002/jlcr.2995. J Labelled Comp Radiopharm. 2013. PMID: 24285324 Review.
Cited by
-
Central nervous system drug development: an integrative biomarker approach toward individualized medicine.NeuroRx. 2005 Oct;2(4):683-95. doi: 10.1602/neurorx.2.4.683. NeuroRx. 2005. PMID: 16489375 Free PMC article. Review.
-
Dose-dependent, saturable occupancy of the metabotropic glutamate subtype 5 receptor by fenobam as measured with [11 C]ABP688 PET imaging.Synapse. 2014 Dec;68(12):565-573. doi: 10.1002/syn.21775. Epub 2014 Aug 19. Synapse. 2014. PMID: 25098663 Free PMC article.
-
Efficient and regioselective halogenations of 2-amino-1,3-thiazoles with copper salts.J Org Chem. 2009 Mar 20;74(6):2578-80. doi: 10.1021/jo802799c. J Org Chem. 2009. PMID: 19231816 Free PMC article.
-
3-Cyano-5-fluoro-N-arylbenzamides as negative allosteric modulators of mGlu(5): Identification of easily prepared tool compounds with CNS exposure in rats.Bioorg Med Chem Lett. 2010 Aug 1;20(15):4390-4. doi: 10.1016/j.bmcl.2010.06.064. Epub 2010 Jun 15. Bioorg Med Chem Lett. 2010. PMID: 20598884 Free PMC article.
-
Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):533-547. doi: 10.1007/s00259-016-3587-y. Epub 2016 Dec 8. Eur J Nucl Med Mol Imaging. 2017. PMID: 27933416 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources